trending Market Intelligence /marketintelligence/en/news-insights/trending/tofe44n0bca9hmqhr5n_ng2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Vifor Pharma director to step down after CEO appointment elsewhere

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Vifor Pharma director to step down after CEO appointment elsewhere

Vifor Pharma AG said its director Marc Garidel will not stand for re-election at its annual shareholder meeting on May 15.

Garidel's decision results from his appointment as CEO of U.S. biotechnology company Corvidia Therapeutics, Inc.

The Swiss drugmaker added it will nominate Jacques Theurillat for election to the board at the shareholder meeting.

Theurillat served from 2008 to 2015 as CEO of Ares Life Sciences AG, a privately held investment fund for life-sciences companies.